| Artículo | 2025 |
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Revisión | 2025 |
Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease
|
Trends in Endocrinology and Metabolism |
| Artículo | 2025 |
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
|
JHEP Reports |
| Artículo | 2025 |
miR-27b-3p modulates liver sinusoidal endothelium dedifferentiation in chronic liver disease
|
HEPATOLOGY COMMUNICATIONS |
| Artículo | 2025 |
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
|
JOURNAL OF HEPATOLOGY |
| Editorial | 2024 |
Alcohol-related liver disease: (Re)compensation of abstinence
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2024 |
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy.
|
Nature Reviews Gastroenterology and Hepatology |
| Artículo | 2024 |
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
|
NATURE METABOLISM |
| Artículo | 2024 |
Biomarcadores en MASLD, ¿estamos ante una nueva era?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2024 |
CLINICAL MANAGEMENT OF DISCREPANCIES BETWEEN FIB-4 AND LIVER STIFFNESS MEASUREMENT IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
|
HEPATOLOGY |
| Resumen congreso | 2024 |
Differential transcriptomic profile in platelet-derived extracellular vesicles in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2024 |
Dysregulation of ureagenesis and glutaminolysis in DIAMONDTM mice played a major role in MASLD progression
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2024 |
ENTPD1/ CD39 REGULATES INFLAMMATORY PROCESS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD)
|
HEPATOLOGY |
| Artículo | 2024 |
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
| Resumen congreso | 2024 |
Identification and assessment of new circulating serological biomarkers for the evaluation of liver disease severity in MASLD patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2024 |
LiverAI: New tool in the landscape for liver health
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2024 |
LONG-TERM LIVER-RELATED OUTCOMES AND LIVER FIBROSIS PROGRESSION OF STATIN USAGE IN STEATOTIC LIVER DISEASE
|
HEPATOLOGY |
| Artículo | 2024 |
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
|
GUT |
| Resumen congreso | 2024 |
NASH-PI: a randomized trial to compare cost-effectiveness across strategies for screening, referring and management of MASLD patients in clinical practice
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2024 |
Novel insights into metabolic-associated steatotic liver disease preclinical models
|
LIVER INTERNATIONAL |
| Resumen congreso | 2024 |
Platelet-derived extracellular vesicles (PEVs) as a potential biomarker for hepatocellular carcinoma (HCC)
|
JOURNAL OF HEPATOLOGY |
| Short Survey | 2024 |
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2024 |
Prognostic significance of a change in liver stiffness measurement by vibration-controlled transient elastography-a multicenter cohort study of 10, 920 patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2024 |
PROGNOSTIC VALUE OF THE AASLD 2-STEP APPROACH IN THE IDENTIFICATION OF ADVANCED LIVER FIBROSIS IN 16,603 PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN THE VCTE-PROGNOSIS STUDY
|
HEPATOLOGY |
| Artículo | 2024 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
|
GUT |
| Artículo | 2024 |
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
|
Journal of Gastroenterology |
| Resumen congreso | 2024 |
Validation of the Baveno VII 'rule of 5' in a real-life multicentre cohort of patients with metabolic dysfunction associated steatotic liver disease
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2024 |
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
|
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| Letter | 2023 |
A second update on mapping the human genetic architecture of COVID-19
|
NATURE |
| Resumen congreso | 2023 |
Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
|
Biomarker Research |
| Artículo | 2023 |
Current dilemmas in hepatitis virus C management. What should we do after achieving sustained virologic response?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2023 |
Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2023 |
Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Resumen congreso | 2023 |
Identification of new serological biomarkers for the detection of significant fibrosis
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Is the fibrosis phenotype in pre- and post-menopausal F2/F3 women the same?
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2023 |
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
|
CELL DEATH & DISEASE |
| Artículo | 2023 |
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
|
LANCET GASTROENTEROLOGY & HEPATOLOGY |
| Artículo | 2023 |
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
|
LIVER INTERNATIONAL |
| Resumen congreso | 2023 |
Serial vibration controlled transient elastography (vcte)-based agile scores predict liver-related events in nonalcoholic fatty liver disease (nafld) - a multicenter cohort study of 16,603 patients
|
HEPATOLOGY |
| Resumen congreso | 2023 |
Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH
|
JOURNAL OF HEPATOLOGY |
| Editorial | 2023 |
What is the Gastroenterologia y Hepatologia journal Young Corner?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2022 |
A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy
|
CANCERS |
| Artículo | 2022 |
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
|
Biomarker Research |
| Artículo | 2022 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
|
GUT |
| Revisión | 2022 |
Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver
|
Frontiers in Endocrinology |
| Artículo | 2022 |
Detailed stratified GWAS analysis for severe COVID-19 in four European populations.
|
HUMAN MOLECULAR GENETICS |
| Artículo | 2022 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
|
GUT |
| Resumen congreso | 2022 |
Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2022 |
EpCAM+CD133+Microvesicles: novel biomarker in NAFLD
|
HEPATOLOGY |
| Resumen congreso | 2022 |
Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase
|
HEPATOLOGY |
| Resumen congreso | 2022 |
Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Artículo | 2022 |
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2022 |
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
|
Scientific reports |
| Artículo | 2022 |
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma
|
LIVER INTERNATIONAL |
| Resumen congreso | 2022 |
Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2022 |
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2022 |
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
|
Journal of Gastroenterology |
| Resumen congreso | 2022 |
The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression
|
JOURNAL OF HEPATOLOGY |
| Revisión | 2021 |
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
|
FRONTIERS IN IMMUNOLOGY |
| Resumen congreso | 2021 |
Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease.
|
ATHEROSCLEROSIS |
| Artículo | 2021 |
Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients
|
WORLD JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2021 |
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
|
EBIOMEDICINE |
| Artículo | 2021 |
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
|
LIVER INTERNATIONAL |
| Artículo | 2021 |
Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis.
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2021 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis
|
Scientific reports |
| Resumen congreso | 2021 |
Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2021 |
Management of NAFLD patients with advanced fibrosis
|
LIVER INTERNATIONAL |
| Artículo | 2021 |
Mapping the human genetic architecture of COVID-19.
|
NATURE |
| Artículo | 2021 |
Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus
|
ADVANCED SCIENCE |
| Letter | 2021 |
Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD”
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2020 |
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
|
LIVER INTERNATIONAL |
| Artículo | 2020 |
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| Corrección | 2020 |
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2020 |
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
|
PLOS ONE |
| Artículo | 2020 |
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study
|
Clinical and translational gastroenterology |
| Resumen congreso | 2020 |
Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2020 |
Lack of histological steatohepatitis features in advanced fibrosis could impact in screening failure rate: a comparison with FDA clinical criteria
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2020 |
Liver derived apoptotic microparticles as biomarkers to detect transition from simple steatosis to steatohepatitis in non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2020 |
LncRNA-H19 as a marker of liver progression from steatosis to hepatocellular carcinoma
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2020 |
Risk factors associated to NAFLD-related advanced fibrosis in patients with normal ALT levels
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2020 |
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2019 |
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3 ' UTR
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2019 |
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-beta 1 dependent mechanisms
|
Scientific reports |
| Artículo | 2019 |
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Artículo | 2019 |
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
|
Revista Española de Enfermedades Digestivas |
| Resumen congreso | 2019 |
Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma
|
HEPATOLOGY |
| Resumen congreso | 2019 |
Effects of fatty acids and polyphenols from extra virgin olive oil in a murine animal dietary model knockout for the LDL receptor
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
Effects of sustained virological response on the endothelial dysfunction and the cardiovascular risk in hepatitis C after direct antiviral angets treatment: HEPCAR study
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
Epigenetic regulation of gene expression in a HCC-NASH murine model
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
Genetic Fingerprint of Hepatic Encephalopathy Risk in Liver Cirrhosis
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
| Artículo | 2019 |
Impaired brain glymphatic flow in experimental hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
| Corrección | 2019 |
Impaired brain glymphatic flow in experimental hepatic encephalopathy (vol 69, pg 40, 2019)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2019 |
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
|
Revista Española de Enfermedades Digestivas |
| Resumen congreso | 2019 |
Oxidized LDL is a distinctive biomarker of NASH independently of liver fibrosis in patients with NAFLD
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
OXIDIZED-LDL AS A MARKER OF OXIDATIVE STRESS IS STRONGLY RELATED TO NASH IRRESPECTIVELY OF INSULIN RESISTANCE AND LIVER FIBROSIS
|
HEPATOLOGY |
| Resumen congreso | 2019 |
The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
Transcriptomic and epigenetic characterization of a NAFLD murine model
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2019 |
UREA CYCLE ENZYMES DYSREGULATION IS LINKED TO A MORE AGGRESSIVE NAFLD PHENOTYPE
|
HEPATOLOGY |
| Resumen congreso | 2018 |
Burden and Variability in the Management of NAFLD Patients in Clinical Practice: Toward Unified Criteria.
|
HEPATOLOGY |
| Resumen congreso | 2018 |
Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2018 |
Dynamic of Microparticles in Patients with Hepatitis C Receiving Daa and Their Impact on Cardiovascular Risk: Hepcar Study
|
HEPATOLOGY |
| Corrección | 2018 |
Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349] Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349]
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2018 |
Fibroblast Growth Factor 21 (FGF21) in NAFLD: From a Biomarker to a Therapeutic Target.
|
HEPATOLOGY |
| Revisión | 2018 |
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| Resumen congreso | 2018 |
Genetic and functional analysis of FGF21 in NAFLD/NASH
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2018 |
Genetic factors of hepatic encephalopathy on patients with cirrhosis: candidate gene study
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2018 |
Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2018 |
Metabolically Healthy Obesity Is a Dynamic Condition Which Progress to Unhealthy Status According to Nash and Fibrosis Stage in Biopsy-Proven NAFLD Patients
|
HEPATOLOGY |
| Resumen congreso | 2018 |
Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2018 |
Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
|
Revista Española de Enfermedades Digestivas |
| Revisión | 2018 |
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2018 |
Mutation analysis of LIPA through NGS in a cohort of 731 patients with nonalcoholic hepatic steatosis and familial hypercholesterolemia
|
European Journal of Human Genetics |
| Artículo | 2018 |
Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype
|
ANNALS OF HEPATOLOGY |
| Resumen congreso | 2018 |
Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma
|
HEPATOLOGY |
| Artículo | 2018 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
|
PLOS ONE |
| Resumen congreso | 2018 |
Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients
|
HEPATOLOGY |
| Artículo | 2018 |
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| Resumen congreso | 2017 |
A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasound
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2017 |
An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice
|
MOLECULAR NUTRITION & FOOD RESEARCH |
| Resumen congreso | 2017 |
Cirrhosis and acute on chronic liver failure: is ammonia a predictor of hepatic encephalopathy and mortality?
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2017 |
IFN-lambda 3, not IFN-lambda 4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis
|
NATURE GENETICS |
| Artículo | 2017 |
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy
|
LIVER INTERNATIONAL |
| Resumen congreso | 2017 |
Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2016 |
Advanced fibrosis is independently associated with impaired kidney function in biopsy-proven NAFLD. Results of a multicenter cross-sectional study
|
HEPATOLOGY |
| Resumen congreso | 2016 |
DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2016 |
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes
|
HEPATOLOGY |
| Artículo | 2016 |
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
|
Scientific reports |
| Resumen congreso | 2016 |
IMPACT OF GWAS-IDENTIFIED COMMON VARIANTS ON HISTOPATHOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2016 |
LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis
|
HEPATOLOGY |
| Artículo | 2016 |
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
|
NATURE COMMUNICATIONS |
| Artículo | 2016 |
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| Resumen congreso | 2016 |
SCCA-IgM helps to identify patients at risk of long-term hepatocelullar carcinoma
|
HEPATOLOGY |
| Resumen congreso | 2016 |
THE FTO RS1421085 T > C POLYMORPHISM IS ASSOCIATED WITH THE SEVERITY OF NON-ALCOHOLIC FATTY LIVER
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2015 |
Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis
|
Revista Española de Enfermedades Digestivas |
| Resumen congreso | 2015 |
Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry
|
HEPATOLOGY |
| Artículo | 2015 |
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
|
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| Editorial | 2015 |
Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field
|
World Journal of Hepatology |
| Resumen congreso | 2015 |
IMPACT OF PHYSICAL ACTIVITY ON OXIDATIVE STRESS IN PATIENTS WITH HEPATITIS C
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2015 |
METFORMIN REDUCES HYPERAMMONEMIA IN PORTACAVAL SHUNTED RATS INHIBITING GLUTAMINASE ACTIVITY
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2015 |
OLIVE OIL COMSUMPTION AMELIORATES NON-ALCOHOLIC STEATOHEPATITIS INDUCED BY HYPERCALORIC AND HYPERLIPIDIC WESTERN DIETS
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2015 |
ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC STEATOHEPATITIS DEVELOPMENT
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2014 |
Bacterial antigen translocation in patients with cirrhosis and minimal hepatic encephalopathy is associated with increased serum ammonia and nitric oxide levels
|
HEPATOLOGY |
| Artículo | 2014 |
Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease
|
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION |
| Resumen congreso | 2014 |
LOSS OF GATA4 IN HEPATIC STELLATE CELLS PROMOTES LIVER FIBROSIS
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2014 |
NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
|
JOURNAL OF HEPATOLOGY |
| Ponencia | 2013 |
Determination of fibrosis stage and steatohepatitis in patients with nafld by optical analysis of magnetic resonance images combined with artificial neural networks (Fibromri and nashmri)
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2013 |
Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
| Resumen congreso | 2013 |
Histological severity independently predicts early atherosclerotic lesions and 10 year cardiovascular risk in NAFLD patients
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2013 |
Influence of PNPLA3 genotypes on histological features and adiponutrin serum levels in patients with NAFLD
|
HEPATOLOGY |
| Resumen congreso | 2013 |
Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk
|
JOURNAL OF HEPATOLOGY |
| Resumen congreso | 2013 |
Serum levels of PNPLA3 are related to the development of steatohepatitis in non alcoholic fatty liver disease patients
|
HEPATOLOGY |
| Ponencia | 2013 |
Usefulness in clinical practice of NASHMRi for the detection of steatohepatitis in patients with NAFLD
|
HEPATOLOGY |
| Ponencia | 2012 |
Anti-LDL-oxidized antibodies: a link between NASH and cardiovascular disease
|
HEPATOLOGY |
| Ponencia | 2012 |
Determination of the presence of Steatohepatitis in Non-Alcoholic Fatty Liver disease based on optical analysis of Liver MRI and artificial neural networks (FibroMRi)
|
HEPATOLOGY |
| Ponencia | 2012 |
METFORMIN PREVENTS OVERT HEPATIC ENCEPHALOPATHY (HE) IN CIRRHOTICS: A RETROSPECTIVE OBSERVATIONAL STUDY
|
JOURNAL OF HEPATOLOGY |
| Ponencia | 2012 |
METFORMIN TREATMENT REDUCES HEPATOCELLULAR CARCINOMA (HCC) RISK IN PATIENTS WITH CIRRHOSIS C: A RETROSPECTIVE OBSERVATIONAL STUDY OF TWO INDEPENDENT COHORTS
|
JOURNAL OF HEPATOLOGY |
| Ponencia | 2012 |
Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis
|
HEPATOLOGY |
| Ponencia | 2012 |
Optical analysis of liver magnetic resonance images based on neural networks for the determination of fibrosis stage and distribution in non-alcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
| Ponencia | 2012 |
Validation of FibroMax and NAFLDscore in a cohort of NAFLD Spanish patients
|
HEPATOLOGY |
| Artículo | 2011 |
Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept
|
Revista Española de Enfermedades Digestivas |
